The digital stutter therapy Speechagain wins this year’s Eugen Münch award for innovative healthcare in the category practical use which is endowed with 20,000 Euro. The startup convinced the 8-member jury made up of journalists, professors, doctors, experienced founders and board members and was able to head a field of 100 competitors.
The Eugen Münch award is awarded annually for innovative and practice-oriented technologies and ideas that ensure access to and/or increase the quality and efficiency of healthcare.
“The awarded works impressively demonstrate that a focus on patients and economic goals are no contradiction” emphasized Stephan Holzinger, chairman of the Münch foundation.
Speechagain is a cloud-based digital stutter therapy that treats stutterers with artificial intelligence and speech recognition analysis according to the highest scientific standards of the S3 guidelines.
The therapy’s scientific foundation was established by Dr. Alexander Wolff von Gudenberg with his hybrid therapy at the Kasseler Stottertherapie institute. Since its founding in 1996 the team of Dr. von Gudenberg could successfully treat more than 3,000 stutterers and earned their reputation as Europe’s leading institute for stutter therapy.
Since the launch of the clinical pre-version of Speechagain as an online therapy more than 1,000 patients were treated. This precursor of the current therapy is already four times as efficient as comparable private therapies in the USA. Speechagain was developed together with Dr. von Gudenberg and his team as well as the Berlin-based company builder Digital Health Factory around Dr. med. Hartwig Jaeger and Dr. med Peter Langkafel. The Digital Health Factory founds and identifies medically advisable and technically feasible innovations focusing on the digitization of the healthcare industry.
“Speechagain, the product of Digithep GmbH you have honored will be available worldwide.
Anywhere, anytime and for anyone. With the help of the German Federal Ministry for Economic Affairs and Energy and the German Accelerator we were able to open an office on Broadway whereby we are initially focusing on earning money. In order to pick up pace in the US as our first market we are always open for conversations with investors and cooperation partners”, as Chief Medical Officer Dr. von Gudenberg points out.